Results 181 to 190 of about 97,766 (255)

International survey in four European countries on diagnostic reference levels based on clinical indications in computed tomography. [PDF]

Insights Imaging
Schegerer AA, Jungnickel K, Walz M, Verius M, Singer J, Renger B, Oberhofer N, Müller C, Menz R, Madsack B, Fiebich M, Eßeling R, Borowski M, Bazrafshan B, Ammon J, Aberle C, Stamm G.   +16 more
europepmc   +1 more source

Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant, Tise Suzuki, Kiera McGivney, V. S. S. Abhinav Ayyadevara, Sharon Asariah, Jay Deng, Ethan Nyein, Jacqueline Coats, Gary Yu, Yevgeniya J. Ioffe, Christian Hurtz, Juli J. Unternaehrer   +11 more
wiley   +1 more source

Timely and Efficient Infant Diagnosis Is Required to End AIDS in Children. [PDF]

J Int AIDS Soc
Vojnov L, Jani IV.
europepmc   +1 more source

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Human Vaccines and Immunotherapeutics: News October 2025

Human Vaccines & Immunotherapeutics
Ronald Ellis, Adam Weiss
doaj   +1 more source

Associations between food insecurity and Supplemental Nutrition Assistance Program participation with ultra-processed food acquisitions for home consumption in US households. [PDF]

Public Health Nutr
Fulay A, Juul F, Wolfson J, Baylin A, Lee J, Martinez-Steele E, Leung C.   +6 more
europepmc   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

A dense longitudinal multimodal single-subject rs-fMRI dataset acquired by self-administered scanning. [PDF]

Sci Data
Petrovskiy ED.
europepmc   +1 more source

Spatial biology in cancer epigenetics

Molecular Oncology, EarlyView.
Spatial epigenomics combines molecular profiling with tissue architecture to reveal how gene regulation is organized within intact tissues. In cancer, these technologies uncover the mechanisms driving tumor heterogeneity and microenvironmental interactions, opening new opportunities for biomarker discovery and precision medicine.
Eva Crespo‐García, Manel Esteller
wiley   +1 more source

A tissue-informed deep learning-based method for positron range correction in preclinical [Formula: see text]Ga PET imaging. [PDF]

EJNMMI Phys
Encina-Baranda N, Paneque-Yunta RJ, Lopez-Rodriguez J, Pratt EC, Nguyen TN, Grimm J, Lopez-Montes A, Herraiz JL.   +7 more
europepmc   +1 more source